Avaliação do Controle da Asma
01.Haselkom T, Fish JE, Zeiger RS, et al. Consistently very poorly controlled asthma, as defined by impairment domain of the Expert Panel Report 3 guidelines increases risk for future severe asthma exacerbations in The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study. J Allergy Clin Immunol 2009;124:898-902.
02.Patel M, Pilcher J, Reffel HK, et al. Metrics of salbutamol use as predictors of future adverse outcomes in asthma. Clin Exp Allergy 2013;43:1144-51.
03.Suissa S, Ernst P, Boivin JF, et al. A cohort analysis of excess mortality in asthma and the use of inhaled beta-agonists. Am J Respir Crit Care Med 1994;149:604-10.
04.Melani AS, Bonavia M, Cilenti V, et al. Inhaler mishandling remains common in real life and in associated with reduced disease control. Respir Med 2011;105:930-8.
05.Fuhlbrigge AL, Kitch BT, Paltiel AD, et al. FEV1 is associated with risk of asthma attacks in a pediatric population. J Allergy Clin Immunol 2001;107:61-7.
06.Osborne ML, Pedula KL, O'Hollaren M, et al. Assessing future need for acute care in adulte asthmatics: the Profile os Asthma Risk Study: a prospective health maintenance organization-based study. Chest 2007;132:1151-61.
07.Sturdy PM, Victor CR, Anderson HR, et al. Psychological, social and health behaviour risk factors for deaths certified as asthma: a national case-control study. Thorax 2002;57:1034-9.
08.Fitzpatrick S, Joks R, Silverberg JI. Obesity is associated with increased asthma severity and exacerbations, and increased serum immunoglobulin E in inner-city adults. Clin Exp Allergy 2012;42:747-59.
09.Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinits and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008;63:Suppl86:8-160.
10.Burks AW, Tang M, Sicherer S, et al. ICON: food allergy. J Allergy Clin Immunol 2012;129:906-20.
11.Belda J, Giner J, Casan P, Sanchis J. Mild exacerbations and eosinophilic inflammation in patients with stable well-controlled asthma after 1 year of follow-up. Chest 2001;119:1011-7.
12.Ulrik CS. Peripheral eosinophil counts as a marker of disease activity in intrinsic and extrinsic asthma. Clin Exp Allergy 1995;25:820-7.
13.Zeiger RS, Schatz M, Zhang F, et al. Elevated exaled nitric oxide is a clinical indicator of future uncontrolled asthma in asthmatic patients on inhaled corticosteroids. J Allergy Clin Immunol 2011;128:412-4.
14.Murphy VE, Clifton VL, Gibson PG. Asthma exacerbations during pregnancy incidence and association with adverse pregnancy outcomes. Thorax 2006;61:169-76.
15.Turner MO, Noertojo K, Vedal S, Bai T, Crump S, FitzGerald JM. Risk factors for near-fatal asthma. A case-control study in hospitalized patients with asthma. Am J Respir Care Med 1998;157:1804-9.
16.Miller MK, Lee JH, Miller DP, Wenzel SE. Recent asthma exacerbations: a key predictor of future exacerbations. Respir Med 2007;101:481-9.
17. O'Byrne PM, Pedersen S, Lamm CJ, Tan WC, Busse WW. Severe exacerbations and decline in lung function in asthma. Am J Respir Crit Care Med 2009;179:19-24.
18.Lange P, Parner J, Vestbo J, Schnohr P, Jensen G. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med 1998;339:1194-200.
19.Baur X, Sigsgaard T, Aasen TB, et al. Guidelines for the management of work-related asthma [Erratum appears in Eur Respir J 2012 Jun:39(6):1553]. Eur Respir J 2012;39:529-45.
20.Ulrik CS. Outcome of asthma: longitudinal changes in lung function. Eur Respi J 1999;13:904-18.
21.Raissy HH, Keççy HW, Harkins M, Szefler SJ. Inhaler corticosteroids in lung diseases. Am J Respir Crit Care Med 2013;187:798-837.
22.Foster JM, Aucott L, van der Werf RH, et al. Higher patient perceived side effects relatet to higher doses of inhaled corticosteroids in the community: a cross-sectional analysis. Respir Med 2006;100:1318-36.
23.Roland NJ, Bhalla RK, Earis J. The local side effects of inhaled corticosteroids: current understanding and review of the literature. Chest 2004;126:213-9.